A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom

References

• Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–1843.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Anaemia - iron deficiency. Clinical Knowledge Summary. Available from: https://cks.nice.org.uk/anaemia-iron-deficiency Last accessed November 13, 2019.
   Google Scholar
• Dignass AU, Gasche C, Bettenworth D, et al. European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211–222.
   PubMed Web of Science ®Google Scholar
• Avni T, Bieber A, Steinmetz T, et al. Treatment of anemia in inflammatory bowel disease–systematic review and meta-analysis. PLoS One. 2013;8(12):e75540.
   PubMed Web of Science ®Google Scholar
• Bonovas S, Fiorino G, Allocca M, et al. Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore)). 2016;95(2):e2308.
   PubMed Web of Science ®Google Scholar
• Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail. 2012;14(4):423–429.
   PubMed Web of Science ®Google Scholar
• O'Lone EL, Hodson EM, Nistor I, et al. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2019;2:CD007857.
   PubMedGoogle Scholar
• Susantitaphong P, Alqahtani F, Jaber BL. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis. Am J Nephrol. 2014;39(2):130–141.
   PubMed Web of Science ®Google Scholar
• Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011;10:CD003094.
   PubMed Web of Science ®Google Scholar
• Pharmacosmos A/S. A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-04). NCT03238911. Available from: https://clinicaltrials.gov/ct2/show/NCT03238911 Last accessed November 10, 2019.
   Google Scholar
• Pharmacosmos A/S. A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia (IDA-05). NCT03237065. Available from: https://clinicaltrials.gov/ct2/show/NCT03237065 Last accessed November 10, 2019.
   Google Scholar
• Wolf M, Rubin J, Achebe M, et al. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA. 2020;323(5):432–443.
   PubMed Web of Science ®Google Scholar
• Aksan A, Işık H, Radeke HH, et al. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45(10):1303–1318.
   PubMed Web of Science ®Google Scholar
• Pollock RF, Muduma G. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment. Expert Rev Hematol. 2019;12(2):129–136.
   PubMed Web of Science ®Google Scholar
• Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–691.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria; 2019. Available from: https://www.R-project.org/ Last accessed November 9, 2019.
   Google Scholar
• Davis S, Stevenson M, Tappenden P, et al. NICE DSU Technical Support Document 15: Cost-Effectiveness Modelling using Patient-Level Simulation. Available from: http://nicedsu.org.uk/wp-content/uploads/2016/03/TSD15_Patient-level_simulation.pdf. Last accessed March 5, 2020.
   Google Scholar
• Pharmacosmos A/S. Monofer 100mg/ml solution for injection/infusion. Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5676/smpc Last accessed November 19, 2019.
   Google Scholar
• Vifor France. Ferinject (ferric carboxymaltose). Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5910 Last accessed November 19, 2019.
   Google Scholar
• Derman R, Roman E, Modiano MR, et al. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. Am J Hematol. 2017;92(3):286–291.
   PubMed Web of Science ®Google Scholar
• Onken JE, Bregman DB, Harrington RA, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant. 2014;29(4):833–842.
   PubMed Web of Science ®Google Scholar
• Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846–853.e1–2.
   Google Scholar
• Mahey R, Kriplani A, Mogili KD, et al. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding. Int J Gynaecol Obstet. 2016;133(1):43–48.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Nadarajah S. Handbook of Beta Distribution and Its Applications. 2004. 1st Edition. CRC Press, Boca Raton, FL, USA. ISBN 9780429152887.
   Google Scholar
• Gavaskar U. A comparison of two elicitation methods for a prior distribution for a binomial parameter. Manag Sci. 1988;34:784–790.
   Web of Science ®Google Scholar
• Brent RP. Algorithms for Minimization without Derivatives. 1973. Prentice-Hall, Englewood Cliffs, NJ, USA. ISBN 0130223352.
   Google Scholar
• Matsumoto M, Nishimura T. Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator. ACM Trans Model Comput Simul. 1998;8(1):3–30.
   Google Scholar
• Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108(12):1877–1888.
   PubMed Web of Science ®Google Scholar
• Frigstad SO, Haaber A, Bajor A, et al. The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency. Gastroenterol Res Pract. 2017;2017:4585164.
   PubMedGoogle Scholar
• Pollock RF, Biggar P. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia. Expert Rev Hematol. 2020;13(2):187–195.
   PubMed Web of Science ®Google Scholar